baber/WOPTO huggingface dataset:
Patent JP-2001519997-A (JP)
IPC: H02J7/00
Filed: 1998-03-24
Abstract: An apparatus for controlling and power feeding a number of power-consuming parts, the apparatus comprising a plurality of external units each comprising a power-consuming part, and a safety module, where each external unit comprising means for transmitting to the safety unit information relating to the power required or desired by the power-consuming part of the external unit during a present or future operation thereof. The safety module is adapted to only provide power for those power-consuming parts which totally consume less power than a maximum power consumption limit. This has the advantage that the operation of the parts is not interrupted due to lack of power. A number of schemes of deciding which of the power consuming parts requesting power is to actually receive power.
Patent JP-2002515976-A (JP)
Title: 超小型精密振動レートジャイロスコープ
IPC: G01C19/5719
Filed: 1997-05-30
Abstract: (57)【要約】
基板の表面に平行な軸の周りでの回転を測定するためのマイクロ製造されたジャイロスコープが提供される。電極フィンガの対間に電圧差が与えられ、直角位相エラーが減少される。マイクロ製造されたジャイロスコープは、振動構造体と、縦横比の大きな櫛型の電極とを備えている。
Patent JP-2002511845-A (JP)
IPC: A61K49/00
Filed: 1998-04-24
Abstract: The invention provides a method of generating an image of an animate human or non-human animal subject previously administered with a contrast agent involving generating an image of at least a part of said subject to which said contrast agent has distributed, characterised in that said contrast agent is a composition of matter of formula I V - L - R where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker moiety or a bond and R is a detectable moiety, characterised in that V is a non-peptidic organic group, or V is peptidic and R is a macromolecular or particulate species providing a multiplicity of labels detectable in in vivo imaging.
Patent MX-157060-A (MX)
Inventor: SOLER JOSE ESTEVE
IPC: C07D513/04
Filed: 1983-06-07
Abstract: This invention relates to new derivatives of oxazinobenzothiazine-6,6-dioxide, to a process for the production thereof and to the use thereof as medicaments. The new derivatives according to the present invention correspond to the general formula I:    <IMAGE>  (I)  wherein: R represents a linear or branched lower C1-C4 alkyl radical, in particular the methyl and ethyl radicals, X represents an oxygen atom or a sulphur atom, and Het represents a mono- or bicyclic unsaturated heterocycle containing a nitrogen heteroatom in the ortho position relative to the link between the said heterocycle and the nitrogen atom of the oxazine ring, the said heterocycle optionally containing one or two other additional heteroatoms selected from nitrogen, oxygen and sulphur, and also being able to be substituted by one or two methyl radicals.
Patent NZ-201538-A (NZ)
Title: Certain 2-(pyrid-2-yl)methylthiobenzimidazoles
Inventor: CARLSSON E I
IPC: C07D401/12
Filed: 1982-08-09
Abstract: A pharmaceutical preparation containing as active ingredient a compound of the formula  <IMAGE>  or a therapeutically acceptable salt thereof in which formula R1 and R2 are the same or different and each selected from the group consisting of H, CF3, NO2, -COOCH3, -COOC2H5, alkyl containing 1-7 carbon atoms, halogen, alkoxy, containing 1-5 carbon atoms, and alkanoyl containing 1-4 carbon atoms; R is selected from the group consisting of H, alkanoyl containing 1-4 carbon atoms, and carboalkoxy containing 2-6 carbon atoms; and R3, R4 and R5, which are the same or different, are each selected from the group consisting of H, CH3, C2H5, OCH3, OC2H5, OCH2CH2OCH3, and OCH2CH2OCH2CH3; provided that (a) at least one of R3, R4 and R5 is selected from the group consisting of CH3, C2H5, OCH3, OC2H5, OCH2CH2OCH3, and OCH2CH2OCH2CH3, and (b) when two of R3, R4 and R5 are H, then the remaining radical R3, R4 or R5 is selected from the group consisting of OCH3, OC2H5, OCH2CH2OCH3, and OCH2CH2OCH2CH3; the use of the compounds for inhibiting gastric acid secretion; compounds included in the formula I, and processes for their preparation.
Patent NZ-202106-A (NZ)
Title: Insecticidal,acaricidal and veterinary parasiticidal compositions containing substituted hydroxy-malonic acid diamides
Inventor: FINDEISEN K
IPC: C07D277/32
Filed: 1982-10-07
Abstract: 1. Substituted hydroxymalonic acid diamides of the formula (I)  see diagramm : EP0076957,P17,F4  in which R represents alkyl with at least 2 C atoms and chlorine substituted alkyl, optionally substituted alkenyl, optionally substituted cycloalkyl, substituted aryl, or optionally substituted heteroaryl.
Patent NZ-206692-A (NZ)
Title: Process for preparing phosphonomethylated amino acids
Inventor: NAGUBANDI S
IPC: C07F9/38
Filed: 1983-12-22
Abstract: A process for preparing phosphonomethylated amino acids comprising protecting a primary amino acid ester or salt with a carbon dioxide protecting group, phosphonomethylating the protected amino compound formed, and removing the carbon dioxide protecting group by acidification.
Patent NZ-222973-A (NZ)
Title: Substituted piperidine and azepine derivatives and pharmaceutical compositions
Inventor: CARLIER P
IPC: C07D223/08
Filed: 1987-12-17
Abstract: Heterocyclic ethers of formula (I) and their salts are new: R and R' = 1-7C alkyl; R1 = H or 1-7C alkyl; R2 and R3 = 1-7C alkyl or phenyl, or CR3R4 = 3-7C cycloalkylidene; n = 2 or 3. Specifically R = Et or i-Bu; R' and R1-R3 = Me.
Patent NZ-233567-A (NZ)
Title: Wire nail with penetrating, wedging and transitional portions
Inventor: SYGNATOR HENRY A
IPC: B25C1/00
Filed: 1990-05-04
Abstract: A wire nail (10) having a shank (12), a head (14) formed on one end of the shank, and a point (16) formed on the other end. The point has a penetrating portion, a wedging portion, and a transitional portion. The wedging portion defines four straight edges, each being inclined at an acute angle relative to an axis defined by the shank. The transitional portion defines four straight edges, each meeting a different one of said edges defined by the wedging portion, and each being inclined at a lesser angle relative to the same axis. The wedging portion has a plurality of convex surfaces, each conforming generally to a section of a circular cylinder. The transitional portion has a plurality of convex surfaces, each conforming generally to a section of a circular cylinder. A cutting tip is formed as a thin rib extended across the penetrating portion. A pair of thin cutting ribs extended from the cutting tip are formed along the wedging and transitional portions.
Patent NZ-241057-A (NZ)
Title: Boat with control tower position located adjacent and above the stern
Inventor: PARASKEVOPOULOS LEO
IPC: B63B15/00
Filed: 1991-12-18
Abstract: PCT No. PCT/AU91/00584 Sec. 371 Date Aug. 16, 1993 Sec. 102(e) Date Aug. 16, 1993 PCT Filed Dec. 17, 1991 PCT Pub. No. WO90/11180 PCT Pub. Date Jul. 9, 1990.A boat having a tower (3) extending upwardly and supporting a con position (7) adjacent the upper end thereof and wherein the con position (7) has a sole (8) having an aft end located not more than 10% of the load waterline length of the boat forward of a stern of the boat.
Patent NZ-249956-A (NZ)
Title: Infusible package; tea/coffee bag with extra length of draw string inside the bag
Inventor: SHAKSPEARE ANTHONY EVAN
IPC: B65D81/00
Filed: 1993-03-26
Abstract: PCT No. PCT/GB93/00620 Sec. 371 Date Jan. 20, 1995 Sec. 102(e) Date Jan. 20, 1995 PCT Filed Mar. 26, 1993 PCT Pub. No. WO94/21361 PCT Pub. Date Sep. 29, 1994An infusible package includes a closed bag, containing an infusible substance for infusion in a liquid. The bag is formed from panels of porous material sealed at their peripheral margins; and at least one string. Each string extends through a seal between the panels, enters the interior of the bag at a point on the peripheral margins and extends across the interior of the bag to an anchoring point at or adjacent the peripheral margins. The length of that portion of each string which extends across the interior of the bag between the point on the peripheral margins and the anchoring point is greater than the distance between that point and the anchoring point. With this arrangement, pulling the string initially causes withdrawal from the bag interior of slack string length disposed therein.
Patent NZ-270976-A (NZ)
Title: Defective identification module: detection at terminal and control station warned
Inventor: JOUIN CHRISTOPHE
IPC: H04W24/00
Filed: 1995-04-21
Abstract: The method involves storing in the terminal memory, a message indicating detection of a problem in reading or writing in the user identification module. The message is displayed on the terminal screen. A warning message (10) indicating the problem is transmitted (16) to the control station as soon as the problem is discovered. A database in the control station is updated (18) to list the identification modules which are defective. A new identification module is then sent (24) to the terminal user. The identification module can be a smart card. <IMAGE>
Patent NZ-310936-A (NZ)
Title: Particulate urea with mineral filler incorporated for hardness
Inventor: AYLEN PETER B
IPC: C05C9/00
Filed: 1996-06-28
Abstract: This particulate urea product has improved anticaking, hardness and nonfriable properties and is useful for either direct application to the soil or as intermediate product for the subsequent incorporation with other fertilizer materials into solid bulk blends.  The product consists of an admixture of urea and a finely divided mineral filler selected from the group consisting of diatomaceous earth, sodium bentonite, calcium bentonite, kaolin, zeolite and ball clay and is in either granular or prill form.
Patent NZ-332718-A (NZ)
Title: Process of purification of cyclosporin A using chromatography with a toluene containing solvent
Inventor: KERI VILMOS
IPC: A61P29/00
Filed: 1998-03-23
Abstract: A purification process for the preparation of cyclosporin A in high purity from a cyclosporin complex containing crude product with a chromatographic method on a silica gel column wherein multistep chromatographic is used with a solvent mixture containing toluene as the main component is claimed.
Patent NZ-333556-A (NZ)
Title: Radiopharmaceutical compositions comprising radioactive metal salts of pyrophosporic acid derivatives and matrices thereof
Inventor: NICOLINI JORGE OSVALDO
IPC: A61B5/055
Filed: 1997-06-17
Abstract: These radio-pharmaceutical composition, which are useful in the treatment of cancer, comprise a radioactive salt of the formula M2+HxP2O7 Where M is a metal ion, x is 0, 1, 2 or 3 and z is 1, 2, 3 or 4; with the proviso that the sum of x and z = 4 and at least one of M, H, P or O comprises a radioisotype; and a pharmaceutical acceptable carrier.
Patent NZ-335260-A (NZ)
Title: Post foot having a right angled triangular shape, each side thereof having a recess with a panel therebetween
Inventor: LEGARTH FREDRICK JOHN
IPC: E04H17/22
Filed: 1999-04-16
Abstract: A post foot 1 suitable for attachment to a post capable of being driven into the ground has a substantially right angled triangular wedge shape.  Foot 1 includes connected first 2 and second 3 faces having a right angular relationship therebetween, and a third face 4 connects the first and second faces to form the hypotenuse of the triangle shape between the first and second faces.  Foot 1 further includes two sides 5, 6 defined by the first, second and third faces.  Each side includes a recess 9 therein.  Each recess 9 is separated by a central panel  10 capable of receiving at least one securing device therethrough from the third face to the first or second face.
Patent NZ-500664-A (NZ)
Title: Process for making flurbiprofen lozenges by granulating flubiprofen with a bulking agent (selected from calcium carbonate, tricalcium phosphate or microcrystalline cellulose)
Inventor: DAY ANDREW
IPC: A61K9/20
Filed: 1998-05-20
Abstract: A process producing a pharmaceutical lozenge formulation comprising the steps of: 1)	granulating a mixture of flurbiprofen and a bulking agent selected from calcium carbonate, tricalcium phosphate or microcrystalline cellulose with a solution of a binding agent in a polar solvent to form granules; 2)	melting a lozenge-forming composition; 3)	mixing the granules with the molten lozenge-forming composition; 4)	forming the resulting mixture into lozenges each containing a therapeutically effective amount of flurbiprofen.
Patent NZ-501712-A (NZ)
Title: A container for separately storing flowable materials but allowing mixing of materials when required
Inventor: HAWTHORNE DONN BEDE
IPC: B65D79/00
Filed: 1998-06-09
Abstract: Disclosed is a container (10) for separately containing a first flowable material (15) and a second flowable material (17) until mixing of the first and second flowable materials is desired comprising: (i) a first chamber (13) containing the first flowable material and having a first head space (14) comprising gas at a pressure greater than or equal to atmospheric pressure; (ii) a second chamber (16) containing the second flowable material, the second flowable material containing gas, and optionally, the second chamber comprising a second head space (18) containing gas at a pressure greater than atmospheric pressure; (iii) means for reducing the pressure in the first chamber; (iv) means (20) for transferring gas between the first and second chambers; and (v) means for transferring the second flowable material into the first flowable material when the pressure in the first chamber is reduced.
Patent NZ-502942-A (NZ)
Title: Toby box with drainage passage under hinge for liquid and detritus to drain away
Inventor: PETRONELLI CLAUDIO
IPC: E03B9/08
Filed: 2000-02-18
Abstract: The term "toby" is a common name given a water stopcock that is perhaps installed at the boundary of a road and a section of land on which a house or building is to be built. A toby allows water supply to the said section to be turned off to facilitate plumbing work that is to be performed on the house or building. The current toby has an annular housing with an opening at its upper end (14). It is said that the upper end is defined by a peripheral rim (18). There is also a lid (26) and a hinge (28) pivotally connecting the lid to an inside part of the rim whereby the lid can be swung between a closed position across the opening and an open position raised substantially clear of the opening. A drainage passage below the hinge whereby liquid and detritus entering about the hinge can be drain or washed away from the hinge to the interior of the housing.
Patent NZ-505266-A (NZ)
Title: Refrigerated portable container using Peltier device
Inventor: WHEELER ARTHUR
IPC: H01L35/32
Filed: 1998-11-24
Abstract: A portable container (10) for receiving contents for transport while regulating the temperature of the contents includes a combined heater and/or cooler in the form of a Peltier effect device (50), a removable inner receptacle (70) for receiving the contents, an air gap around the outside of the inner receptacle, and a control unit (62) for controlling the Peltier effect device so as to regulate the temperature of the air around the outside of the inner receptacle and thereby regulate the temperature of the contents of the inner receptacle. The control unit can have a temperature logging system for recording the temperature history of the contents of the container.
Patent NZ-508663-A (NZ)
Title: A dry powder inhaler with a vibrator to deaggregate the powder and feedback control for controlling dosing
Inventor: ABRAMS ANDREW L
IPC: A61M15/00
Filed: 1999-06-14
Abstract: A dry powder inhaler comprises a first chamber, a vibrator operatively connected to the first chamber, second chamber and electronic circuitry with feedback control for controlling dosage. In the first chamber a dry powder is deaggregated by the vibrator and separated by size. In the second chamber the size separated deaggregated powder is picked up by an air stream generated during inhalation by a patient through an opening in the inhaler and is carried into the patient. The inhaler may further comprise more than one vibrator that are designed to vibrate at different frequencies.
Patent NZ-513382-A (NZ)
Title: Disposable sleeve heat shrunk to water bottle upper portion
Inventor: CLARK DAVID W
IPC: B65D41/48
Filed: 1999-12-29
Abstract: A disposable sleeve (20) that can be applied to a water bottle (10) before leaving the filling source and heat-shrunk take the configuration of the upper portion of the bottle including the cap (11) and shoulder and anchor the same to the bottle. Optionally, the cover which has a neck (12), shoulder (14) and body portion can be provided with a removal tab (19). Important to the invention, however, is the securing of the sleeve to the bottle in an intimate skin-to-skin relationship which thereby shields the upper portion of the bottle from contamination wherever it may be prior to use. In accordance with the method, the sleeve heat-shrunk to the bottle and is removed prior to emptying the bottle. The bottle is then uncapped and secured to the cooler. The sleeve should not be allowed to touch any portion of the bottle or cooler after its removal.
Patent NZ-524147-A (NZ)
Title: Anti-TNF antibodies, compositions, methods and uses
Inventor: GILES-KOMAR JILL
IPC: A61K39/00
Filed: 2001-08-07
Abstract: At least one isolated mammalian anti-TNF antibody, an isolated nucleic acid encoding at least one such antibody, vectors, host cells and compositions comprising the same, as well as methods of production and use in the preparation of medicaments.
Patent NZ-524520-A (NZ)
Title: Composite light weight building panel and core material therefor
Inventor: VILLANI GIANCARLO ANTONIO
IPC: C04B28/02
Filed: 2001-08-03
Abstract: A  core material for a composite light weight building panel  formed  from a settable mixture that incorporates  an acrylic,  polymer-based resin, cement,  water  and  a  light weight filler material in the following ratios: from 1 to  3 litres  of cement; more than 2 litres of resin; from  10  to 100 litres of light weight filler material; and less than  6 kilograms of water, such that the volume of cement  is  more than half the volume of resin. The resin comprises: 85 %  by volume  water based copolymer emulsion of polyvinyl  acetate with   versatate  and/or  acrylic  copolymers  in  a   water emulsion;  10  %  water  soluble  colloid  protector;  5   % additives;  such  that the resin obtains a specific  gravity in  the  range of 1000 +/- 50g/l and an 8 Ford viscosity  at 20 DEG C of 7 +/- 1.
Patent NZ-526023-A (NZ)
Title: Inhalable formulation of a solution containing a tiotropium salt
Inventor: NIKLAUS-HUMKE BARBARA
IPC: A61K47/10
Filed: 2001-10-24
Abstract: Describes a propellant-free inhalable pharmaceutical preparation comprising a tiotropium salt as active substance, in a concentration based on tiotropium of between 0.0005 and 5 % by weight, water on its own or a water/ethanol mixture as solvent for the active substance, acid for achieving a pH between 2.0 and 3.1, a preservative, editic acid or a salt thereof in an amount of greater than 0 up to 25 mg/100 ml, optionally a cosolvent and/or other adjuvants and additives in addition to the preservative. Describes the use of the pharmaceutical preparation for nebulising in an inhaler, and as a medicament including for the treatment of asthma and/or COPD.
Patent NZ-526822-A (NZ)
Title: Methods for the production of multimeric proteins for producing an oil body associated with a recombinant protein complex preferably thioredoxin or an immunoglobin, in transgenic plants and their use in compositons for reducing allergenicity of food
Inventor: VAN ROOIJEN GIJS
IPC: A61K38/00
Filed: 2001-12-19
Abstract: A method for producing an oil body associated with a recombinant multimeric-protein-complex comprising producing in a non-human cell comprising oil bodies a first recombinant polypeptide and second recombinant polypeptide wherein the first polypeptide is capable of associating with the second polypeptide to form the multimeric-protein-complex and associating the complex with an oil through and oil-body-targeting -protein capable of associating with the oil body and the first polypeptide. Preferably the oil-body targeting protein is oleosin or caleosin, the first polypeptide thioredoxin and the second polypeptide thioredoxin-reductase. Chimeric nucleic acid constructs, recombinant fusion proteins and methods of producing recombinant multimeric protein complexes, preferably in plants, are also described. Compositions comprising the oil bodies and polypeptides can be used in food products, for treating COPD, cataracts, diabetes, envenomation, bronchiopulmonary disease, malignancies, psoriasis, reperfusion injury, wound healing, sepsis, GI bleeding, IBD, ulcers, and GERD.
Patent NZ-528660-A (NZ)
Inventor: FIELD ADRIAN BRUCE
IPC: B65D5/22
Filed: 2003-10-03
Abstract: A stackable core sample trough is disclosed that can nest within another such trough.
Patent NZ-529513-A (NZ)
Title: Toluene sulfonamide-containing anti-tumor composition and method of use thereof
Inventor: WU JOHN
IPC: A61P35/00
Filed: 2002-04-16
Abstract: A pharmaceutical composition exhibiting anti-tumor activity, the composition comprising less than 10%, by weight, of a toluene sulfonamide and a pharmaceutically acceptable aqueous carrier selected from the group consisting of an injectable carrier, an infusible carrier and a palatable orally-administrable carrier.
Patent NZ-546842-A (NZ)
Title: Diagnosis and treatment of tumors
Inventor: GURNEY AUSTIN L
Filed: 2002-10-16
Abstract: A method for the diagnosis and treatment of a tumour in an isolated or a non-human mammal cell that expresses a specific Tumour-associated Antigenic Target (TAT) polypeptide of SEQ ID NO: 6. The use of such a method is also disclosed.
Patent NZ-549226-A (NZ)
Title: Multi layered wound dressing
Inventor: SHAW HELEN
IPC: A61F13/00
Filed: 2005-02-11
Abstract: A multi-layered would dressing for use on wounds which exude excessively has a transmission layer 12 having a moisture vapour transmission rate (MVTR) of at least 300 gm2/24 hrs, an absorbent core 16 of gel forming fibres capable of absorbing and retaining exudate, a wound contacting layer 18 of gel forming fibres which transmits exudate to the absorbent core 16, and a keying layer 19, 19' positioned on the absorbent core. The absorbent core and the wound contacting layer limit the lateral spread of exudate in the dressing to the region of the wound. The gel forming fibres may be carboxymethylated cellulose fibres in the form of a fabric. The dressing may include other layers such as a spreading layer 20 and adhesive layer 14.
Patent NZ-553629-A (NZ)
Title: Glyphosate formulations with early burndown symptoms
Inventor: WRIGHT DANIEL R
IPC: A01N37/02
Filed: 2005-09-15
Abstract: Disclosed is an aqueous ready-to-use herbicidal composition comprising: between 0.1-5% by weight (a.e.) of a glyphosate component comprising N-(phosphonomethyl)glycine, an agronomically acceptable salt of N-(phosphonomethyl)glycine or a mixture thereof; between 1.5-5% by weight (a.e.) of a fatty acid component predominantly comprising at least one C8 to C12 saturated, straight or branched chain fatty acid or an agronomically acceptable salt thereof; and between 0.5-4% by weight of an agronomically acceptable inorganic ammonium salt. Preferred combinations include pelargonic acid as the fatty acid, and ammonium sulfate as the ammonium salt.
Patent NZ-562409-A (NZ)
Title: Use of barusiban in assisted reproduction
Inventor: KUCZYNSKI WALDEMAR
IPC: A61K38/095
Filed: 2006-05-10
Abstract: Disclosed is the use of barusiban for the manufacture of a medicament for an improved uterine receptivity in assisted reproduction.